Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting
- PMID: 17174652
- DOI: 10.1016/j.ahj.2006.09.009
Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting
Abstract
Background: There are little contemporary data available describing the hospital and long-term outcomes of patients with peripheral arterial disease (PAD) who are hospitalized with acute myocardial infarction (AMI). The objectives of our population-based study were to examine the hospital and long-term outcomes, as well as the use of different treatment practices, among patients with established PAD who were hospitalized with AMI.
Methods: The study sample consisted of 4480 patients hospitalized with AMI at all Worcester, Mass, medical centers in 4 alternate years between 1997 and 2003.
Results: Among the metropolitan Worcester residents hospitalized with AMI, 13.5% had a history of PAD. Prior use of proven cardiac therapies in patients with, and without, PAD was less than optimal though more often used in patients with prior PAD. Patients with PAD were significantly less likely to be treated with thrombolytic therapy during hospitalization than patients without PAD. Patients with PAD were not at significantly increased risk of dying during hospitalization (adjusted OR 1.29, 0.95% CI 0.97-1.71), though they were at a significantly increased risk of dying at 1 year after hospital discharge (adjusted OR 2.00, 95% CI 1.58-2.52) in comparison with patients without prior PAD.
Conclusions: Approximately 1 in 8 patients presenting with AMI in this community-wide study had a history of clinically recognized PAD. These patients are at increased risk of dying during the first year after hospital discharge. Our data indicate that there is a room for improvement for the enhanced use of effective treatment modalities and implementation of secondary prevention strategies in these high-risk patients.
Similar articles
-
Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective.Am Heart J. 2001 Oct;142(4):594-603. doi: 10.1067/mhj.2001.117776. Am Heart J. 2001. PMID: 11579348
-
Communitywide trends in the use and outcomes associated with beta-blockers in patients with acute myocardial infarction: the Worcester Heart Attack Study.Arch Intern Med. 2003 Oct 13;163(18):2175-83. doi: 10.1001/archinte.163.18.2175. Arch Intern Med. 2003. PMID: 14557215
-
Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.Eur J Vasc Endovasc Surg. 2008 Jan;35(1):51-8. doi: 10.1016/j.ejvs.2007.08.008. Epub 2007 Oct 17. Eur J Vasc Endovasc Surg. 2008. PMID: 17923426
-
Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention.J Vasc Nurs. 2009 Jun;27(2):26-30. doi: 10.1016/j.jvn.2009.03.001. J Vasc Nurs. 2009. PMID: 19486852 Review.
-
Peripheral arterial disease: a review of disease awareness and management.Am J Geriatr Pharmacother. 2006 Dec;4(4):365-79. doi: 10.1016/j.amjopharm.2006.12.006. Am J Geriatr Pharmacother. 2006. PMID: 17296541 Review.
Cited by
-
Evaluation of the consequences associated with diffuse vascular disease history in patients diagnosed with peripheral arterial disease: estimates from Saskatchewan health data.BMC Cardiovasc Disord. 2010 Sep 2;10:40. doi: 10.1186/1471-2261-10-40. BMC Cardiovasc Disord. 2010. PMID: 20813057 Free PMC article.
-
Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):541-9. doi: 10.1161/CIRCOUTCOMES.111.964379. Epub 2012 Jun 19. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22715460 Free PMC article.
-
The prognostic value of peripheral artery diseases in patients with ST-segment elevation myocardial infarction.Dis Markers. 2013;35(6):877-82. doi: 10.1155/2013/487807. Epub 2013 Dec 14. Dis Markers. 2013. PMID: 24415828 Free PMC article.
-
Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies.J Cardiovasc Pharmacol. 2017 Jan;69(1):48-54. doi: 10.1097/FJC.0000000000000440. J Cardiovasc Pharmacol. 2017. PMID: 27798417 Free PMC article.
-
Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis.Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2018-2032. doi: 10.1161/ATVBAHA.120.314774. Epub 2020 Jul 9. Arterioscler Thromb Vasc Biol. 2020. PMID: 32640905 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical